Tempus AI (NASDAQ:TEM) Earns Outperform Rating from Analysts at Wolfe Research

Analysts at Wolfe Research initiated coverage on shares of Tempus AI (NASDAQ:TEM) in a research report issued to clients and investors on Friday. The firm set an “outperform” rating and a $60.00 price target on the stock. Wolfe Research’s price objective would indicate a potential upside of 42.89% from the company’s previous close.

Several other equities analysts have also recently commented on TEM. Bank of America cut Tempus AI from a “buy” rating to a “neutral” rating and increased their target price for the company from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Guggenheim began coverage on shares of Tempus AI in a report on Monday. They set a “buy” rating and a $74.00 price objective for the company. Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their target price for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Piper Sandler reaffirmed a “neutral” rating and set a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Finally, Loop Capital lifted their price target on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research note on Tuesday, October 15th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Tempus AI currently has an average rating of “Moderate Buy” and an average price target of $56.55.

Tempus AI Trading Down 2.8 %

Shares of TEM stock opened at $41.99 on Friday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The business has a fifty day moving average price of $52.88. Tempus AI has a 12 month low of $22.89 and a 12 month high of $79.49.

Insider Buying and Selling

In other Tempus AI news, major shareholder Bradley A. Keywell sold 395,800 shares of the company’s stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the sale, the insider now directly owns 16,164,449 shares of the company’s stock, valued at approximately $694,263,084.55. This represents a 2.39 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently made changes to their positions in TEM. First Horizon Advisors Inc. acquired a new stake in shares of Tempus AI during the third quarter worth $30,000. Sandia Investment Management LP acquired a new stake in Tempus AI during the 2nd quarter worth about $136,000. Vestor Capital LLC purchased a new stake in Tempus AI during the third quarter valued at about $153,000. Stifel Financial Corp acquired a new position in shares of Tempus AI in the third quarter worth about $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in shares of Tempus AI in the third quarter worth approximately $258,000. 24.22% of the stock is currently owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.